{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:23:30Z","timestamp":1794583410041,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T00:00:00Z","timestamp":1615766400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A2C1088965"],"award-info":[{"award-number":["NRF-2019R1A2C1088965"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003654","name":"Korea Environmental Industry and Technology Institute","doi-asserted-by":"publisher","award":["2020002960007"],"award-info":[{"award-number":["2020002960007"]}],"id":[{"id":"10.13039\/501100003654","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003654","name":"Korea Environmental Industry and Technology Institute","doi-asserted-by":"publisher","award":["2020002960007"],"award-info":[{"award-number":["2020002960007"]}],"id":[{"id":"10.13039\/501100003654","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Li Kashing foundation","award":["LD030302"],"award-info":[{"award-number":["LD030302"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Demyelination leads to a loss of neurons, which results in, among other consequences, a severe reduction in locomotor function, and underlies several diseases in humans including multiple sclerosis and polyneuropathies. Considerable clinical progress has been made in counteracting demyelination. However, there remains a need for novel methods that reduce demyelination while concomitantly achieving remyelination, thus complementing the currently available tools to ameliorate demyelinating diseases. In this study, we used an established zebrafish demyelination model to test selected compounds, following a screening in cell culture experiments and in a mouse model of spinal cord injury that was aimed at identifying beneficial functions of the neural cell adhesion molecule L1. In comparison to mammalian nervous system disease models, the zebrafish allows testing of potentially promotive compounds more easily than what is possible in mammals. We found that our selected compounds tacrine and duloxetine significantly improved remyelination in the peripheral and central nervous system of transgenic zebrafish following pharmacologically induced demyelination. Given that both molecules are known to positively affect functions other than those related to L1 and in other disease contexts, we propose that their combined beneficial function raises hope for the use of these compounds in clinical settings.<\/jats:p>","DOI":"10.1038\/s41598-021-85412-1","type":"journal-article","created":{"date-parts":[[2021,3,15]],"date-time":"2021-03-15T11:03:41Z","timestamp":1615806221000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Small compounds mimicking the adhesion molecule L1 improve recovery in a zebrafish demyelination model"],"prefix":"10.1038","volume":"11","author":[{"given":"Suhyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Won","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melitta","family":"Schachner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hae-Chul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,15]]},"reference":[{"key":"85412_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.devcel.2015.01.016","volume":"32","author":"KK Bercury","year":"2015","unstructured":"Bercury, K. K. & Macklin, W. B. Dynamics and mechanisms of CNS myelination. Dev. Cell 32, 447\u2013458. https:\/\/doi.org\/10.1016\/j.devcel.2015.01.016 (2015).","journal-title":"Dev. Cell"},{"key":"85412_CR2","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nature11314","volume":"487","author":"Y Lee","year":"2012","unstructured":"Lee, Y. et al. Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 487, 443\u2013448. https:\/\/doi.org\/10.1038\/nature11314 (2012).","journal-title":"Nature"},{"key":"85412_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jneuroim.2006.11.026","volume":"184","author":"O Aktas","year":"2007","unstructured":"Aktas, O., Waiczies, S. & Zipp, F. Neurodegeneration in autoimmune demyelination: recent mechanistic insights reveal novel therapeutic targets. J. Neuroimmunol. 184, 17\u201326. https:\/\/doi.org\/10.1016\/j.jneuroim.2006.11.026 (2007).","journal-title":"J. Neuroimmunol."},{"key":"85412_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3389\/fnmol.2015.00035","volume":"8","author":"A Alizadeh","year":"2015","unstructured":"Alizadeh, A., Dyck, S. M. & Karimi-Abdolrezaee, S. Myelin damage and repair in pathologic CNS: challenges and prospects. Front. Mol. Neurosci. 8, 35. https:\/\/doi.org\/10.3389\/fnmol.2015.00035 (2015).","journal-title":"Front. Mol. Neurosci."},{"key":"85412_CR5","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/nrn917","volume":"3","author":"RJ Franklin","year":"2002","unstructured":"Franklin, R. J. Why does remyelination fail in multiple sclerosis?. Nat. Rev. Neurosci. 3, 705\u2013714. https:\/\/doi.org\/10.1038\/nrn917 (2002).","journal-title":"Nat. Rev. Neurosci."},{"key":"85412_CR6","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/nrn2480","volume":"9","author":"RJ Franklin","year":"2008","unstructured":"Franklin, R. J. & Ffrench-Constant, C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9, 839\u2013855. https:\/\/doi.org\/10.1038\/nrn2480 (2008).","journal-title":"Nat. Rev. Neurosci."},{"key":"85412_CR7","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.3389\/fimmu.2018.02784","volume":"9","author":"KK Thompson","year":"2018","unstructured":"Thompson, K. K., Nissen, J. C., Pretory, A. & Tsirka, S. E. Tuftsin combines with remyelinating therapy and improves outcomes in models of CNS demyelinating disease. Front. Immunol. 9, 2784. https:\/\/doi.org\/10.3389\/fimmu.2018.02784 (2018).","journal-title":"Front. Immunol."},{"key":"85412_CR8","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/nature12647","volume":"502","author":"VA Deshmukh","year":"2013","unstructured":"Deshmukh, V. A. et al. A regenerative approach to the treatment of multiple sclerosis. Nature 502, 327\u2013332. https:\/\/doi.org\/10.1038\/nature12647 (2013).","journal-title":"Nature"},{"key":"85412_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1111\/j.1527-3458.2004.tb00029.x","volume":"10","author":"KC Hayes","year":"2004","unstructured":"Hayes, K. C. The use of 4-aminopyridine (fampridine) in demyelinating disorders. CNS Drug Rev. 10, 295\u2013316. https:\/\/doi.org\/10.1111\/j.1527-3458.2004.tb00029.x (2004).","journal-title":"CNS Drug Rev."},{"key":"85412_CR10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/bs.mcb.2016.08.001","volume":"138","author":"M D'Rozario","year":"2017","unstructured":"D\u2019Rozario, M., Monk, K. R. & Petersen, S. C. Analysis of myelinated axon formation in zebrafish. Methods Cell Biol. 138, 383\u2013414. https:\/\/doi.org\/10.1016\/bs.mcb.2016.08.001 (2017).","journal-title":"Methods Cell Biol."},{"key":"85412_CR11","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s10059-013-0087-9","volume":"36","author":"AY Chung","year":"2013","unstructured":"Chung, A. Y. et al. Generation of demyelination models by targeted ablation of oligodendrocytes in the zebrafish CNS. Mol. Cells 36, 82\u201387. https:\/\/doi.org\/10.1007\/s10059-013-0087-9 (2013).","journal-title":"Mol. Cells"},{"key":"85412_CR12","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tins.2017.03.003","volume":"40","author":"V Sytnyk","year":"2017","unstructured":"Sytnyk, V., Leshchyns\u2019ka, I. & Schachner, M. Neural cell adhesion molecules of the immunoglobulin superfamily regulate synapse formation, maintenance, and function. Trends Neurosci. 40, 295\u2013308. https:\/\/doi.org\/10.1016\/j.tins.2017.03.003 (2017).","journal-title":"Trends Neurosci."},{"key":"85412_CR13","doi-asserted-by":"publisher","first-page":"4461","DOI":"10.1007\/s12035-015-9352-6","volume":"53","author":"H Kataria","year":"2016","unstructured":"Kataria, H., Lutz, D., Chaudhary, H., Schachner, M. & Loers, G. Small molecule agonists of cell adhesion molecule L1 mimic L1 functions in vivo. Mol. Neurobiol. 53, 4461\u20134483. https:\/\/doi.org\/10.1007\/s12035-015-9352-6 (2016).","journal-title":"Mol. Neurobiol."},{"key":"85412_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1242\/bio.201410736","volume":"4","author":"Y Fang","year":"2014","unstructured":"Fang, Y. et al. A novel model of demyelination and remyelination in a GFP-transgenic zebrafish. Biol. Open 4, 62\u201368. https:\/\/doi.org\/10.1242\/bio.201410736 (2014).","journal-title":"Biol. Open"},{"key":"85412_CR15","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3233\/RNN-170808","volume":"36","author":"R Li","year":"2018","unstructured":"Li, R., Sahu, S. & Schachner, M. Phenelzine, a small organic compound mimicking the functions of cell adhesion molecule L1, promotes functional recovery after mouse spinal cord injury. Restor. Neurol. Neurosci. 36, 469\u2013483. https:\/\/doi.org\/10.3233\/RNN-170808 (2018).","journal-title":"Restor. Neurol. Neurosci."},{"key":"85412_CR16","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.pbb.2018.05.013","volume":"171","author":"R Li","year":"2018","unstructured":"Li, R., Sahu, S. & Schachner, M. Phenelzine, a cell adhesion molecule L1 mimetic small organic compound, promotes functional recovery and axonal regrowth in spinal cord-injured zebrafish. Pharmacol. Biochem. Behav. 171, 30\u201338. https:\/\/doi.org\/10.1016\/j.pbb.2018.05.013 (2018).","journal-title":"Pharmacol. Biochem. Behav."},{"key":"85412_CR17","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1586\/14737175.8.4.527","volume":"8","author":"N Muller","year":"2008","unstructured":"Muller, N., Schennach, R., Riedel, M. & Moller, H. J. Duloxetine in the treatment of major psychiatric and neuropathic disorders. Expert Rev. Neurother. 8, 527\u2013536. https:\/\/doi.org\/10.1586\/14737175.8.4.527 (2008).","journal-title":"Expert Rev. Neurother."},{"key":"85412_CR18","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1177\/106002809402800612","volume":"28","author":"ML Crismon","year":"1994","unstructured":"Crismon, M. L. Tacrine: first drug approved for Alzheimer\u2019s disease. Ann. Pharmacother. 28, 744\u2013751. https:\/\/doi.org\/10.1177\/106002809402800612 (1994).","journal-title":"Ann. Pharmacother."},{"key":"85412_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1111\/jnc.12705","volume":"130","author":"VE Miron","year":"2014","unstructured":"Miron, V. E. & Franklin, R. J. Macrophages and CNS remyelination. J. Neurochem. 130, 165\u2013171. https:\/\/doi.org\/10.1111\/jnc.12705 (2014).","journal-title":"J. Neurochem."},{"key":"85412_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s12035-016-0254-z","volume":"55","author":"S Sahu","year":"2018","unstructured":"Sahu, S. et al. A small organic compound mimicking the L1 cell adhesion molecule promotes functional recovery after spinal cord injury in Zebrafish. Mol. Neurobiol. 55, 859\u2013878. https:\/\/doi.org\/10.1007\/s12035-016-0254-z (2018).","journal-title":"Mol. Neurobiol."},{"key":"85412_CR21","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.3892\/mmr.2019.10374","volume":"20","author":"K Sharma","year":"2019","unstructured":"Sharma, K. Cholinesterase inhibitors as Alzheimer\u2019s therapeutics (Review). Mol. Med. Rep. 20, 1479\u20131487. https:\/\/doi.org\/10.3892\/mmr.2019.10374 (2019).","journal-title":"Mol. Med. Rep."},{"key":"85412_CR22","doi-asserted-by":"publisher","first-page":"728983","DOI":"10.1155\/2012\/728983","volume":"2012","author":"M Mehta","year":"2012","unstructured":"Mehta, M., Adem, A. & Sabbagh, M. New acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Int. J. Alzheimers Dis. 2012, 728983. https:\/\/doi.org\/10.1155\/2012\/728983 (2012).","journal-title":"Int. J. Alzheimers Dis."},{"key":"85412_CR23","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1002\/glia.23101","volume":"65","author":"RD Fields","year":"2017","unstructured":"Fields, R. D., Dutta, D. J., Belgrad, J. & Robnett, M. Cholinergic signaling in myelination. Glia 65, 687\u2013698. https:\/\/doi.org\/10.1002\/glia.23101 (2017).","journal-title":"Glia"},{"key":"85412_CR24","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.biopsych.2006.08.020","volume":"62","author":"G Bartzokis","year":"2007","unstructured":"Bartzokis, G. Acetylcholinesterase inhibitors may improve myelin integrity. Biol. Psychiatry 62, 294\u2013301. https:\/\/doi.org\/10.1016\/j.biopsych.2006.08.020 (2007).","journal-title":"Biol. Psychiatry"},{"key":"85412_CR25","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/s41401-018-0206-4","volume":"40","author":"X Cui","year":"2019","unstructured":"Cui, X. et al. Donepezil, a drug for Alzheimer\u2019s disease, promotes oligodendrocyte generation and remyelination. Acta Pharmacol. Sin. 40, 1386\u20131393. https:\/\/doi.org\/10.1038\/s41401-018-0206-4 (2019).","journal-title":"Acta Pharmacol. Sin."},{"key":"85412_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4103\/0976-0105.177703","volume":"7","author":"AB Nair","year":"2016","unstructured":"Nair, A. B. & Jacob, S. A simple practice guide for dose conversion between animals and human. J. Basic Clin. Pharma 7, 27\u201331. https:\/\/doi.org\/10.4103\/0976-0105.177703 (2016).","journal-title":"J. Basic Clin. Pharma"},{"key":"85412_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1177\/039463201002300204","volume":"23","author":"D De Berardis","year":"2010","unstructured":"De Berardis, D. et al. The effect of newer serotonin-noradrenalin antidepressants on cytokine production: a review of the current literature. Int. J. Immunopathol. Pharmacol. 23, 417\u2013422. https:\/\/doi.org\/10.1177\/039463201002300204 (2010).","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"85412_CR28","doi-asserted-by":"publisher","first-page":"9934","DOI":"10.1523\/JNEUROSCI.1004-18.2018","volume":"38","author":"M Kremer","year":"2018","unstructured":"Kremer, M. et al. A dual noradrenergic mechanism for the relief of neuropathic allodynia by the antidepressant drugs duloxetine and amitriptyline. J. Neurosci. 38, 9934\u20139954. https:\/\/doi.org\/10.1523\/JNEUROSCI.1004-18.2018 (2018).","journal-title":"J. Neurosci."},{"key":"85412_CR29","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1100\/tsw.2008.140","volume":"8","author":"T Schmitz","year":"2008","unstructured":"Schmitz, T. & Chew, L. J. Cytokines and myelination in the central nervous system. Sci. World J. 8, 1119\u20131147. https:\/\/doi.org\/10.1100\/tsw.2008.140 (2008).","journal-title":"Sci. World J."},{"key":"85412_CR30","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s002130050555","volume":"136","author":"JP Reneric","year":"1998","unstructured":"Reneric, J. P. & Lucki, I. Antidepressant behavioral effects by dual inhibition of monoamine reuptake in the rat forced swimming test. Psychopharmacology 136, 190\u2013197. https:\/\/doi.org\/10.1007\/s002130050555 (1998).","journal-title":"Psychopharmacology"},{"key":"85412_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1097\/FBP.0000000000000140","volume":"26","author":"S Hasebe","year":"2015","unstructured":"Hasebe, S. et al. Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice. Behav. Pharmacol. 26, 681\u2013690. https:\/\/doi.org\/10.1097\/FBP.0000000000000140 (2015).","journal-title":"Behav. Pharmacol."},{"key":"85412_CR32","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1007\/s00192-017-3424-2","volume":"29","author":"A Wrobel","year":"2018","unstructured":"Wrobel, A., Rechberger, E. & Rechberger, T. The influence of duloxetine on detrusor overactivity in rats with depression induced by 13-cis-retinoic acid. Int. Urogynecol. J. 29, 987\u2013995. https:\/\/doi.org\/10.1007\/s00192-017-3424-2 (2018).","journal-title":"Int. Urogynecol. J."},{"key":"85412_CR33","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ntt.2017.10.009","volume":"69","author":"H Richendrfer","year":"2018","unstructured":"Richendrfer, H. & Creton, R. Cluster analysis profiling of behaviors in zebrafish larvae treated with antidepressants and pesticides. Neurotoxicol. Teratol. 69, 54\u201362. https:\/\/doi.org\/10.1016\/j.ntt.2017.10.009 (2018).","journal-title":"Neurotoxicol. Teratol."},{"key":"85412_CR34","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1517\/17460441.2012.693912","volume":"7","author":"S Torres-Sanchez","year":"2012","unstructured":"Torres-Sanchez, S., Perez-Caballero, L., Mico, J. A., Elorza, J. & Berrocoso, E. Preclinical discovery of duloxetine for the treatment of depression. Expert Opin. Drug Discov. 7, 745\u2013755. https:\/\/doi.org\/10.1517\/17460441.2012.693912 (2012).","journal-title":"Expert Opin. Drug Discov."},{"key":"85412_CR35","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/glia.21260","volume":"60","author":"EJ Munzel","year":"2012","unstructured":"Munzel, E. J. et al. Claudin k is specifically expressed in cells that form myelin during development of the nervous system and regeneration of the optic nerve in adult zebrafish. Glia 60, 253\u2013270. https:\/\/doi.org\/10.1002\/glia.21260 (2012).","journal-title":"Glia"},{"key":"85412_CR36","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/j.1440-169X.2008.01044.x","volume":"50","author":"K Asakawa","year":"2008","unstructured":"Asakawa, K. & Kawakami, K. Targeted gene expression by the Gal4-UAS system in zebrafish. Dev. Growth Differ. 50, 391\u2013399. https:\/\/doi.org\/10.1111\/j.1440-169X.2008.01044.x (2008).","journal-title":"Dev. Growth Differ."},{"key":"85412_CR37","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1182\/blood-2010-10-31412037","volume":"117","author":"F Ellett","year":"2011","unstructured":"Ellett, F., Pase, L., Hayman, J. W., Andrianopoulos, A. & Lieschke, G. J. mpeg1 promoter transgenes direct macrophage-lineage expression in zebrafish. Blood 117, e49\u2013e56. https:\/\/doi.org\/10.1182\/blood-2010-10-31412037 (2011).","journal-title":"Blood"},{"key":"85412_CR38","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1097\/00001756-200209160-00007","volume":"13","author":"HT Kim","year":"2002","unstructured":"Kim, H. T. et al. Specific plasticity of parallel fiber\/Purkinje cell spine synapses by motor skill learning. NeuroReport 13, 1607\u20131610. https:\/\/doi.org\/10.1097\/00001756-200209160-00007 (2002).","journal-title":"NeuroReport"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85412-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85412-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T05:17:28Z","timestamp":1670044648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85412-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85412"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85412-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,15]]},"assertion":[{"value":"9 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5878"}}